Interpace Biosciences, Inc. (IDXG)
2.04
-0.07
(-3.33%)
USD |
OTCM |
May 07, 11:05
Interpace Biosciences Market Cap : 56.51M for May 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 119.08M |
| Thermo Fisher Scientific, Inc. | 175.19B |
| XWELL, Inc. | 10.07M |
| Hypha Labs, Inc. | 4.632M |
| Veracyte, Inc. | 3.234B |
Market Cap Related Metrics
| PE Ratio | 2.665 |
| PS Ratio | 1.153 |
| Price to Book Value | 2.527 |
| Price to Free Cash Flow | 8.153 |
| Price | 2.04 |
| Earnings Yield | 37.52% |
| Operating PE Ratio | 10.93 |
| Normalized PE Ratio | 2.680 |